GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » NonCurrent Deferred Liabilities

Xintela AB (OSTO:XINT) NonCurrent Deferred Liabilities : kr0.00 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Xintela AB NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Xintela AB's non-current deferred liabilities for the quarter that ended in Mar. 2025 was kr0.00 Mil.

Xintela AB NonCurrent Deferred Liabilities Historical Data

The historical data trend for Xintela AB's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xintela AB NonCurrent Deferred Liabilities Chart

Xintela AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xintela AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Xintela AB NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Xintela AB's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Xintela AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
XSAT:CESSA OSTO:GUARD OSTO:LIPUM OSTO:ACTI OSTO:ELIC OSTO:IVACC OSTO:XBRANE OSTO:IRLAB A OSTO:KDEV OSTO:IMMU VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Medicon Village, Lund, SWE, 22381
Website
https://www.xintela.se
Xintela AB is a biomedical company that develops stem cell-based treatments with a focus on osteoarthritis and hard-to-heal leg wounds as well as, through the wholly-owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancers such as triple-negative breast cancer and the brain tumor glioblastoma.

Xintela AB Headlines

No Headlines